Nor-UDCA intermediate, Nor-UDCA and preparation method of intermediate thereof
Compounds (I) and (II) were prepared by passing CO2 gas through a solvent and adding sodium hypochlorite aqueous solution dropwise. Nor-UDCA was then synthesized via a redox reaction, which solved the problems of low synthesis efficiency or low purity of Nor-UDCA in the prior art and achieved high yield and high purity of Nor-UDCA synthesis.
Patent Information
- Application Number
- CN202111082597.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2021-09-15
- Publication Date
- 2024-11-15
- Estimated Expiration
- 2041-09-15
AI Technical Summary
There are few existing methods for synthesizing Nor-UDCA, and traditional methods may suffer from low efficiency or low purity.
Using sepholesic acid as a raw material, compounds (I) and (II) were prepared by passing CO2 gas through a solvent and adding sodium hypochlorite aqueous solution of a specific concentration. Nor-UDCA was then synthesized through oxidation and reduction reactions.
A high-yield and high-purity synthesis of Nor-UDCA was achieved, providing a simple and efficient synthetic route.
Smart Images

Figure CN115806578B_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of organic synthesis and medicine, and in particular to a Nor-UDCA intermediate, and a preparation method of Nor-UDCA and the intermediate thereof. Background Art
[0002] Primary sclerosing cholangitis (PSC) is a chronic cholestatic disease characterized by inflammation and fibrosis of the intrahepatic and extrahepatic bile ducts, leading to multifocal bile duct strictures. Most patients eventually develop cirrhosis, portal hypertension, and hepatic decompensation.
[0003] Ursodeoxycholic acid (UDCA) can be used to treat various hepatobiliary diseases, but the controversy over its use in the treatment of PSC focuses on the toxicity that may be caused by high doses. In the guidelines for medication by EASL and AASLD, UDCA is not recommended for the treatment of PSC (Karlsen et al Dig Liver Dis'2010). Nor-UDCA is an analogue of ursodeoxycholic acid with the side chain of C24 shortened to C23. Like UDCA, it can affect the biological properties of bile acid and is used to treat various hepatobiliary diseases. Although the structure of Nor-UDCA is highly similar to UDCA, it produces different biological properties when used in mammals.
[0004]
[0005] Studies have shown that Nor-UDCA can improve liver damage in the mouse model of PSC and is more effective than UDCA in improving liver function, inflammation and fibrosis markers, and inducing and transporting bile acid detoxification enzymes. Nor-UDCA can induce bile acid detoxification through hydroxylation, sulfation and glucuronidation, increase water solubility to obtain less toxic bile acid metabolites, and dilute the toxicity of bile acid in the bile duct. In addition, Nor-UDCA can induce the production of bile-derived bicarbonate, which can release reactive oxygen species and is an effective scavenger that can dilute toxic bile and protect bile duct epithelial cells from oxidative stress. This effect can rebuild the barrier function of bile duct epithelial cells, stop the development of peribiliary inflammation, and reduce the accompanying peribiliary fibrosis and bile duct epithelial cell damage in the bile duct lumen. The bicarbonate-rich bile secreted after the use of Nor-UDCA is of great significance for the treatment of a variety of human biliary diseases. Nor-UDCA can be used alone or in combination with other drugs to treat biliary diseases, including primary sclerosing cholangitis (PSC), primary biliary cholangitis (PBC), etc.
[0006] Nor-UDCA can also be used to treat various liver diseases, such as progressive familial intrahepatic cholestasis, cystic fibrosis, drug-induced cholestasis or liver diseases caused by non-cholestasis, such as chronic viral hepatitis (B, C, D), alcoholic and non-alcoholic fatty hepatitis, autoimmune hepatitis, hemochromatosis, Wilson's disease, α1-antitrypsin deficiency. In addition, Nor-UDCA can also be used as a drug formula for (chemical) prevention of liver cancer, especially hepatocellular carcinoma and cholangiocarcinoma, and can also be used for chronic liver transplant rejection and non-suppurative destructive cholangitis. In particular, some diseases caused by bile duct damage may be treated with drugs containing Nor-UDCA. In addition, Nor-UDCA also has anti-inflammatory and anti-fibrotic effects, and can be used alone or with other non-steroidal anti-inflammatory drugs (NSAIDs) to form a new anti-inflammatory drug formula.
[0007] In summary, Nor-UDCA can treat many human biliary diseases, especially those caused by bile duct damage; it has a significant anti-inflammatory effect on the peribiliary bile duct, and can be used independently or in combination with other non-steroidal anti-inflammatory drugs to treat inflammation of the portal vein and hepatic lobule; it can protect bile duct epithelial cells and play an anti-fibrosis role from the inside of the bile duct; it is expected to be used in the prevention and treatment of liver cancer, such as hepatocellular carcinoma, hepatic cholangiocarcinoma, etc.; in particular, Nor-UDCA has a significant therapeutic effect on PSC, and has low toxicity with few side effects. Therefore, Nor-UDCA has a good prospect for clinical application, and the research on its synthesis process has a good market value.
[0008] Currently, there are few reports on the synthesis method of Nor-UDCA. Patent WO2012 / 07268A1 discloses a synthesis method of Nor-UDCA. The patent route uses ursodeoxycholic acid (UDCA) as a starting material and obtains Nor-UDCA through a 5-step reaction. The synthesis route is as follows:
[0009] Summary of the invention
[0010] Based on this, the object of the present invention is to provide a new method for preparing Nor-UDCA.
[0011] In order to achieve the above object, the present invention first provides a new intermediate compound (I) that can be used to synthesize Nor-UDCA and a preparation method thereof.
[0012] The specific technical solutions are as follows:
[0013] A compound having the structure shown in formula (I):
[0014]
[0015] A method for preparing compound (I), comprising the following steps:
[0016] Dissolve seal bile acid in a solvent, pass CO2 gas into the resulting solution, then dropwise add sodium hypochlorite aqueous solution, stir and react to obtain the product; the reaction formula is as follows:
[0017]
[0018] The solvent is methanol, or a mixed solvent of methanol and water;
[0019] The mass concentration of sodium hypochlorite in the sodium hypochlorite aqueous solution is 2-10%.
[0020] The addition of the sodium hypochlorite aqueous solution and the stirring reaction are both carried out while the CO2 gas is introduced.
[0021] In some embodiments, the preparation method of compound (I) comprises the following steps:
[0022] Dissolve seal bile acid in a solvent, and introduce CO2 gas into the obtained reaction solution. After continuously introducing CO2 gas for 10-60 minutes, add sodium hypochlorite aqueous solution dropwise into the reaction solution while continuing to introduce CO2 gas, and stir the reaction while continuing to introduce CO2 gas to obtain the product.
[0023] In some of the embodiments, the flow rate of CO2 gas introduced into every 20 mL of reaction solution is 2 mL / min-10 mL / min.
[0024] In some of the embodiments, the flow rate of CO2 gas introduced into every 20 mL of reaction solution is 5 mL / min-8 mL / min.
[0025] In some embodiments, the solvent is a mixed solvent of methanol and water in a volume ratio of 1-5:1.
[0026] In some embodiments, the solvent is a mixed solvent of methanol and water in a volume ratio of 2-4:1.
[0027] In some embodiments, the mass concentration of sodium hypochlorite in the sodium hypochlorite aqueous solution is 4-6%.
[0028] In some embodiments, the mass concentration of sodium hypochlorite in the sodium hypochlorite aqueous solution is 4.5-5.5%.
[0029] In some of the embodiments, the ratio of the seal cholic acid and the sodium hypochlorite aqueous solution is 1g:5mL-20mL.
[0030] In some of the embodiments, the ratio of the seal cholic acid and the sodium hypochlorite aqueous solution is 1g:5mL-15mL.
[0031] In some of the embodiments, the ratio of the seal cholic acid and the sodium hypochlorite aqueous solution is 1g:8mL-12mL.
[0032] In some of the embodiments, the ratio of phobic acid to solvent is 1 g: 15 mL-25 mL.
[0033] In some of the embodiments, the ratio of seal cholic acid to solvent is 1g:18mL-22mL.
[0034] In some embodiments, the stirring reaction temperature is 0°C-40°C.
[0035] In some embodiments, the stirring reaction temperature is 5°C-30°C.
[0036] In some embodiments, the stirring reaction time is 1h-6h.
[0037] In some embodiments, the stirring reaction time is 1 h-3 h.
[0038] A method for preparing compound (II), comprising the following steps:
[0039] Dissolve compound (I) in a solvent, pass CO2 gas into the resulting solution, then dropwise add sodium hypochlorite aqueous solution, stir to react, and obtain;
[0040] The reaction formula is as follows:
[0041]
[0042] The mass concentration of sodium hypochlorite in the sodium hypochlorite aqueous solution is 7-15%.
[0043] The addition of the sodium hypochlorite aqueous solution and the stirring reaction are both carried out while the CO2 gas is introduced.
[0044] In some embodiments, the preparation method of compound (II) comprises the following steps:
[0045] Dissolve compound (I) in a solvent, and introduce CO2 gas into the resulting reaction solution. After continuously introducing CO2 gas for 10 to 60 minutes, add dropwise an aqueous sodium hypochlorite solution into the reaction solution while continuing to introduce CO2 gas, and stir the reaction while continuing to introduce CO2 gas to obtain the product.
[0046] In some of the embodiments, the flow rate of CO2 gas introduced in the preparation step of compound (II) is 2 mL / min-10 mL / min.
[0047] In some of the embodiments, the flow rate of CO2 gas introduced in the preparation step of compound (II) is 5 mL / min-8 mL / min.
[0048] In some of the embodiments, the mass concentration of sodium hypochlorite in the sodium hypochlorite aqueous solution in the preparation step of compound (II) is 9-11%.
[0049] In some embodiments, the solvent in the preparation step of compound (II) is methanol.
[0050] In some of the embodiments, the ratio of compound (I) to aqueous sodium hypochlorite solution in the preparation step of compound (II) is 1 g: 5 mL-20 mL.
[0051] In some of the embodiments, the ratio of compound (I) to aqueous sodium hypochlorite solution in the preparation step of compound (II) is 1 g: 8 mL-15 mL.
[0052] In some of the embodiments, the ratio of compound (I) to solvent in the preparation step of compound (II) is 1 g:15-mL35 mL.
[0053] In some of the embodiments, the ratio of compound (I) to solvent in the preparation step of compound (II) is 1 g: 20 mL-30 mL.
[0054] In some of the embodiments, the stirring reaction in the preparation step of compound (II) is carried out at a temperature of 50° C. to 70° C. and for a time of 2 hours to 5 hours.
[0055] The invention also provides a method for preparing Nor-UDCA.
[0056] The specific technical solutions are as follows:
[0057] A method for preparing Nor-UDCA comprises the following steps:
[0058] (1) preparing the compound (II) by the method for preparing the compound (II);
[0059] (2) Compound (II) is subjected to an oxidation reaction to obtain compound (III);
[0060] (3) the compound (III) is subjected to a reduction reaction to obtain the Nor-UDCA;
[0061] The reaction formula is as follows:
[0062]
[0063] In some embodiments, step (2) comprises: under the action of an acid, the compound (II) undergoes an oxidation reaction with an oxidant to obtain the compound (III); the acid is hydrochloric acid, HOAc or H3PO4; and the oxidant is an aqueous solution of sodium hypochlorite.
[0064] In some embodiments, the solvent for the oxidation reaction in step (2) is methanol.
[0065] In some of the embodiments, in step (2), the mass concentration of sodium hypochlorite in the sodium hypochlorite aqueous solution is 2-10%.
[0066] In some embodiments, the molar ratio of compound (II) to acid in step (2) is 1:2.5-3.5.
[0067] In some embodiments, the ratio of the compound (II) to the aqueous sodium hypochlorite solution in step (2) is 1 g: 5 mL-15 mL.
[0068] In some embodiments, the oxidation reaction in step (2) is carried out at a temperature of 10° C. to 30° C. and for a time of 1 hour to 4 hours.
[0069] In some embodiments, step (3) comprises: under the catalysis of pyridine and palladium on carbon, the compound (III) undergoes a reduction reaction with hydrogen to obtain the Nor-UDCA.
[0070] In some embodiments, the solvent for the reduction reaction in step (3) is methanol.
[0071] In some of the embodiments, the palladium carbon in step (3) is 10% palladium carbon, and the ratio of compound (III), pyridine and palladium carbon is 1g:0.0005mL-0.0015mL:0.04g-0.06g.
[0072] In some embodiments, the pressure of the hydrogen in step (3) is 4 MPa-6 MPa.
[0073] In some embodiments, the reduction reaction in step (3) is carried out at a temperature of 40° C. to 60° C. and for a time of 8 hours to 12 hours.
[0074] The present invention uses seal cholic acid as a raw material, selects a suitable solvent, introduces carbon dioxide gas into a seal cholic acid solution, and then drips a sodium hypochlorite aqueous solution of a specific concentration, so as to obtain a new compound of the structure shown in formula (I) of the present invention with high yield and high purity. The compound can be used as an intermediate for synthesizing the compound Nor-UDCA, and the compound Nor-UDCA can be synthesized with high yield and high purity through oxidation and reduction reactions, thereby obtaining a new method for synthesizing Nor-UDCA very simply and conveniently. DETAILED DESCRIPTION
[0075] The technical scheme of the present invention is further illustrated by specific examples below. Those skilled in the art should understand that the examples are only to help understand the present invention and should not be regarded as specific limitations of the present invention.
[0076] Unless otherwise defined, all technical and scientific terms used in the present invention have the same meaning as those commonly understood by those skilled in the art of the present invention. The terms used in the specification of the present invention are only for the purpose of describing specific embodiments and are not intended to limit the present invention.
[0077] The terms "including" and "having" and any variations thereof of the present invention are intended to cover non-exclusive inclusions. For example, a process, method, device, product or equipment comprising a series of steps is not limited to the listed steps or modules, but may optionally include steps not listed, or may optionally include other steps inherent to these processes, methods, products or equipment.
[0078] In the present invention, the term "multiple" refers to two or more than two. "And / or" describes the association relationship of associated objects, indicating that three relationships may exist. For example, A and / or B can represent the following three situations: A exists alone, A and B exist at the same time, and B exists alone. The character " / " generally indicates that the associated objects are in an "or" relationship.
[0079] In the following examples, the English abbreviation "PhCA" refers to phocholic acid; "Nor-CDCA-23-aldehyde" refers to compound (I), "Nor-CDCA" refers to compound (II), and "Nor-CDCA 7k" refers to compound (III), and their structural formulas are as follows:
[0080]
[0081] The following are specific embodiments.
[0082] Example 1 Preparation of Nor-CDCA-23-aldehyde
[0083]
[0084] PhCA (1 g, 2.45 mmol) and 20 mL of a mixed solvent of methanol and water (CH3OH:H2O=3:1 (volume ratio)) were added to a 100 mL three-necked flask in sequence, stirred to dissolve, and then CO2 gas was introduced into the reaction solution (flow rate 6 mL / min). After continuously introducing CO2 gas for 30 minutes, 10 mL of sodium hypochlorite aqueous solution (mass concentration of NaClO is 5%, and it takes about 20 minutes to add) was slowly added to the reaction solution at 25°C and maintaining the CO2 gas flow rate (6 mL / min), and then the reaction was continued to stir at 25°C and maintaining the CO2 gas flow rate (6 mL / min) for 2 hours. TLC detected that the raw material reaction was complete. To the reaction mixture was added 5 mL of saturated sodium thiosulfate solution, and the mixture was stirred for 15 minutes to remove excess sodium hypochlorite. Methanol was evaporated under reduced pressure, and then extracted with ethyl acetate. The organic phases were combined, dried over anhydrous sodium sulfate, and filtered. The filtrate was concentrated under reduced pressure to remove the solvent, and 0.71 g of white solid Nor-CDCA-23-aldehyde was obtained by column chromatography. The yield was 80%, and the purity was 97.6%.
[0085] 1 H NMR (300MHz, CDCl3): δ (ppm) = 9.75 (m, 1H, CHO), 3.48 (s, 1H), 3.43-3.47 (m, 1H), 2.43-2.47 (m, 1H), 2.17- 2.20(m,2H),1.98-2.1(m,3H),1.84-1.91(m,3H),1.22-1.67(m,17H),1.0(m,4H),0.9(m,3H),0.7(m,3H).
[0086] Example 2 Preparation of Nor-CDCA-23-aldehyde
[0087] PhCA (1 g, 2.45 mmol) and 20 mL methanol were added to a 100 mL three-necked flask in sequence, stirred and dissolved, and then CO2 gas (flow rate 6 mL / min) was introduced into the reaction solution. After continuous introduction of CO2 gas for 30 minutes, 10 mL sodium hypochlorite aqueous solution (the mass concentration of NaClO was 5%, and it was added in about 20 min) was slowly added to the reaction solution at 25°C and the CO2 gas flow rate (6 mL / min), and then the reaction was continued to be stirred for 2 hours at 25°C and the CO2 gas flow rate (6 mL / min). TLC detected that the raw material reaction was complete, 5 mL saturated sodium thiosulfate solution was added to the reaction mixture, stirred for 15 minutes to remove excess sodium hypochlorite, methanol was evaporated under reduced pressure, and then extracted with ethyl acetate, the organic phases were combined, dried over anhydrous sodium sulfate, filtered, and the filtrate was concentrated under reduced pressure to remove the solvent, and column chromatography was used to separate 0.62 g of white solid Nor-CDCA-23-aldehyde, with a yield of 70% and a purity of 97.0%.
[0088] Example 3 Preparation of Nor-CDCA-23-aldehyde
[0089] PhCA (1 g, 2.45 mmol) and 20 mL of a mixed solvent of methanol and water (CH3OH:H2O=1:3 (volume ratio)) were added to a 100 mL three-necked flask in sequence, stirred to dissolve, and then CO2 gas was introduced into the reaction solution (flow rate 6 mL / min). After continuously introducing CO2 gas for 30 minutes, 10 mL of sodium hypochlorite aqueous solution (mass concentration of NaClO is 5%, and it takes about 20 minutes to add) was slowly added to the reaction solution at 25°C and maintaining the CO2 gas flow rate (6 mL / min), and then the reaction was continued to stir at 25°C and maintaining the CO2 gas flow rate (6 mL / min) for 2 hours. TLC detected that the raw material reaction was complete. To the reaction mixture was added 5 mL of saturated sodium thiosulfate solution, and the mixture was stirred for 15 minutes to remove excess sodium hypochlorite. Methanol was evaporated under reduced pressure, and then extracted with ethyl acetate. The organic phases were combined, dried over anhydrous sodium sulfate, and filtered. The filtrate was concentrated under reduced pressure to remove the solvent, and 0.52 g of white solid Nor-CDCA-23-aldehyde was obtained by column chromatography. The yield was 58%, and the purity was 97.2%.
[0090] Example 4 Preparation of Nor-CDCA-23-aldehyde
[0091] PhCA (1 g, 2.45 mmol) and 20 mL of a mixed solvent of methanol and water (CH3OH:H2O=3:1 (volume ratio)) were added to a 100 mL three-necked flask in sequence, stirred to dissolve, and then CO2 gas was introduced into the reaction solution (flow rate 6 mL / min). After continuously introducing CO2 gas for 10 minutes, 10 mL of sodium hypochlorite aqueous solution (mass concentration of NaClO is 5%, and it takes about 20 minutes to add) was slowly added to the reaction solution at 25°C and maintaining the CO2 gas flow rate (6 mL / min), and then the reaction was continued to stir at 25°C and maintaining the CO2 gas flow rate (6 mL / min) for 2 hours. TLC detected that the reaction of the raw materials was complete. To the reaction mixture was added 5 mL of saturated sodium thiosulfate solution, and the mixture was stirred for 15 minutes to remove excess sodium hypochlorite. Methanol was evaporated under reduced pressure, and then extracted with ethyl acetate. The organic phases were combined, dried over anhydrous sodium sulfate, and filtered. The filtrate was concentrated under reduced pressure to remove the solvent, and 0.68 g of white solid Nor-CDCA-23-aldehyde was obtained by column chromatography. The yield was 77% and the purity was 97.3%.
[0092] Example 5 Preparation of Nor-CDCA-23-aldehyde
[0093] PhCA (1 g, 2.45 mmol) and 20 mL of a mixed solvent of methanol and water (CH3OH:H2O=3:1 (volume ratio)) were added to a 100 mL three-necked flask in sequence, stirred to dissolve, and then CO2 gas was introduced into the reaction solution (flow rate 6 mL / min). After continuously introducing CO2 gas for 60 minutes, 10 mL of sodium hypochlorite aqueous solution (mass concentration of NaClO is 5%, and it takes about 20 minutes to add) was slowly added to the reaction solution at 25°C and maintaining the CO2 gas flow rate (6 mL / min), and then the reaction was continued to stir at 25°C and maintaining the CO2 gas flow rate (6 mL / min) for 2 hours. TLC detected that the raw material reaction was complete. To the reaction mixture was added 5 mL of saturated sodium thiosulfate solution, and the mixture was stirred for 15 minutes to remove excess sodium hypochlorite. Methanol was evaporated under reduced pressure, and then extracted with ethyl acetate. The organic phases were combined, dried over anhydrous sodium sulfate, and filtered. The filtrate was concentrated under reduced pressure to remove the solvent, and 0.73 g of white solid Nor-CDCA-23-aldehyde was obtained by column chromatography. The yield was 82%, and the purity was 97.0%.
[0094] Example 6 Preparation of Nor-CDCA-23-aldehyde
[0095] PhCA (1 g, 2.45 mmol) and 20 mL of a mixed solvent of methanol and water (CH3OH:H2O=3:1 (volume ratio)) were added to a 100 mL three-necked flask in sequence, stirred to dissolve, and then CO2 gas was introduced into the reaction solution (flow rate 2 mL / min). After continuously introducing CO2 gas for 30 minutes, 10 mL of sodium hypochlorite aqueous solution (mass concentration of NaClO is 5%, and it takes about 20 minutes to add) was slowly added to the reaction solution at 25°C and maintaining the CO2 gas flow rate (2 mL / min), and then the reaction was continued to stir at 25°C and maintaining the CO2 gas flow rate (2 mL / min) for 2 hours. TLC detected that the raw material reaction was complete. To the reaction mixture was added 5 mL of saturated sodium thiosulfate solution, and the mixture was stirred for 15 minutes to remove excess sodium hypochlorite. Methanol was evaporated under reduced pressure, and then extracted with ethyl acetate. The organic phases were combined, dried over anhydrous sodium sulfate, and filtered. The filtrate was concentrated under reduced pressure to remove the solvent, and 0.51 g of white solid Nor-CDCA-23-aldehyde was obtained by column chromatography. The yield was 57% and the purity was 95.4%.
[0096] Example 7 Preparation of Nor-CDCA-23-aldehyde
[0097] PhCA (1 g, 2.45 mmol) and 20 mL of a mixed solvent of methanol and water (CH3OH:H2O=3:1 (volume ratio)) were added to a 100 mL three-necked flask in sequence, stirred to dissolve, and then CO2 gas was introduced into the reaction solution (flow rate 10 mL / min). After continuously introducing CO2 gas for 30 minutes, 10 mL of sodium hypochlorite aqueous solution (mass concentration of NaClO is 5%, and it takes about 20 minutes to add) was slowly added to the reaction solution at 25°C and maintaining the CO2 gas flow rate (2 mL / min), and then the reaction was continued to stir at 25°C and maintaining the CO2 gas flow rate (2 mL / min) for 2 hours. TLC detected that the raw material reaction was complete. To the reaction mixture was added 5 mL of saturated sodium thiosulfate solution, and the mixture was stirred for 15 minutes to remove excess sodium hypochlorite. Methanol was evaporated under reduced pressure, and then extracted with ethyl acetate. The organic phases were combined, dried over anhydrous sodium sulfate, and filtered. The filtrate was concentrated under reduced pressure to remove the solvent, and 0.70 g of white solid Nor-CDCA-23-aldehyde was obtained by column chromatography. The yield was 79%, and the purity was 96.1%.
[0098] Example 8 Preparation of Nor-CDCA-23-aldehyde
[0099] PhCA (1 g, 2.45 mmol) and 20 mL of a mixed solvent of methanol and water (CH3OH:H2O=3:1 (volume ratio)) were added in sequence to a 100 mL three-necked flask, and then CO2 gas was introduced into the reaction solution (flow rate 6 mL / min). After continuously introducing CO2 gas for 30 minutes, 10 mL of sodium hypochlorite aqueous solution (mass concentration of NaClO is 10%, and it takes about 20 minutes to add) was slowly added dropwise to the reaction solution at 25°C and maintaining the CO2 gas flow rate (6 mL / min), and then the reaction was continued to stir at 25°C and maintaining the CO2 gas flow rate (6 mL / min) for 2 hours. TLC detected that the reaction of the raw materials was complete. 10 mL of saturated sodium thiosulfate solution was added to the reaction mixture, and the mixture was stirred for 15 minutes to remove excess sodium hypochlorite. Methanol was evaporated under reduced pressure, and then extracted with ethyl acetate. The organic phases were combined, dried over anhydrous sodium sulfate, and filtered. The filtrate was concentrated under reduced pressure to remove the solvent, and 0.50 g of white solid Nor-CDCA-23-aldehyde was obtained by column chromatography. The yield was 56% and the purity was 97.2%.
[0100] Example 9 Preparation of Nor-CDCA-23-aldehyde
[0101] PhCA (1 g, 2.45 mmol) and 20 mL of a mixed solvent of methanol and water (CH3OH:H2O=3:1 (volume ratio)) were added in sequence to a 100 mL three-necked flask, and then CO2 gas was introduced into the reaction solution (flow rate 6 mL / min). After continuously introducing CO2 gas for 30 minutes, 10 mL of sodium hypochlorite aqueous solution (mass concentration of NaClO is 2%, and the addition takes about 20 min) was slowly added dropwise to the reaction solution at 25°C and maintaining the CO2 gas flow rate (6 mL / min), and then the reaction was continued to stir at 25°C and maintaining the CO2 gas flow rate (6 mL / min) for 2 hours. TLC detected that the raw material reaction was complete. To the reaction mixture was added 10 mL of saturated sodium thiosulfate solution, and the mixture was stirred for 15 minutes to remove excess sodium hypochlorite. Methanol was evaporated under reduced pressure, and then extracted with ethyl acetate. The organic phases were combined, dried over anhydrous sodium sulfate, and filtered. The filtrate was concentrated under reduced pressure to remove the solvent, and 0.58 g of white solid Nor-CDCA-23-aldehyde was obtained by column chromatography. The yield was 65%, and the purity was 95.2%.
[0102] Example 10 Preparation of Nor-CDCA-23-aldehyde
[0103] PhCA (1 g, 2.45 mmol) and 20 mL of a mixed solvent of methanol and water (CH3OH:H2O=3:1 (volume ratio)) were added to a 100 mL three-necked flask in sequence, stirred to dissolve, and then CO2 gas was introduced into the reaction solution (flow rate 6 mL / min). After continuously introducing CO2 gas for 30 minutes, 20 mL of sodium hypochlorite aqueous solution (mass concentration of NaClO is 5%, and the addition takes about 20 minutes) was slowly added dropwise to the reaction solution at 25°C and maintaining the CO2 gas flow rate (6 mL / min), and then the reaction was continued to stir at 25°C and maintaining the CO2 gas flow rate (6 mL / min) for 2 hours. TLC detected that the raw material reaction was complete. To the reaction mixture was added 10 mL of saturated sodium thiosulfate solution, and the mixture was stirred for 15 minutes to remove excess sodium hypochlorite. Methanol was evaporated under reduced pressure, and then extracted with ethyl acetate. The organic phases were combined, dried over anhydrous sodium sulfate, and filtered. The filtrate was concentrated under reduced pressure to remove the solvent, and 0.46 g of white solid Nor-CDCA-23-aldehyde was obtained by column chromatography. The yield was 52%, and the purity was 96.5%.
[0104] Example 11 Preparation of Nor-CDCA-23-aldehyde
[0105] PhCA (1 g, 2.45 mmol) and 20 mL of a mixed solvent of methanol and water (CH3OH:H2O=3:1 (volume ratio)) were added to a 100 mL three-necked flask in sequence, stirred to dissolve, and then CO2 gas was introduced into the reaction solution (flow rate 6 mL / min). After continuously introducing CO2 gas for 30 minutes, 5 mL of sodium hypochlorite aqueous solution (mass concentration of NaClO is 5%, and the addition takes about 20 minutes) was slowly added to the reaction solution at 25°C and maintaining the CO2 gas flow rate (6 mL / min), and then the reaction was continued to stir at 25°C and maintaining the CO2 gas flow rate (6 mL / min) for 2 hours. TLC detected that the raw material reaction was complete. To the reaction mixture was added 5 mL of saturated sodium thiosulfate solution, and the mixture was stirred for 15 minutes to remove excess sodium hypochlorite. Methanol was evaporated under reduced pressure, and then extracted with ethyl acetate. The organic phases were combined, dried over anhydrous sodium sulfate, and filtered. The filtrate was concentrated under reduced pressure to remove the solvent, and 0.61 g of white solid Nor-CDCA-23-aldehyde was obtained by column chromatography. The yield was 69% and the purity was 96.3%.
[0106] Example 12 Preparation of Nor-CDCA-23-aldehyde
[0107] PhCA (1 g, 2.45 mmol) and 20 mL of a mixed solvent of methanol and water (CH3OH:H2O=3:1 (volume ratio)) were added to a 100 mL three-necked flask in sequence, stirred to dissolve, and then CO2 gas was introduced into the reaction solution (flow rate 6 mL / min). After continuously introducing CO2 gas for 30 minutes, 10 mL of sodium hypochlorite aqueous solution (mass concentration of NaClO is 5%, and it takes about 20 minutes to add) was slowly added to the reaction solution at 5°C and maintaining the CO2 gas flow rate (6 mL / min), and then the reaction was continued to stir at 25°C and maintaining the CO2 gas flow rate (6 mL / min) for 2 hours. TLC detected that the raw material reaction was complete. 5 mL of saturated sodium thiosulfate solution was added to the reaction mixture, and the mixture was stirred for 15 minutes to remove excess sodium hypochlorite. Methanol was evaporated under reduced pressure, and then extracted with ethyl acetate. The organic phases were combined, dried over anhydrous sodium sulfate, and filtered. The filtrate was concentrated under reduced pressure to remove the solvent, and 0.69 g of white solid Nor-CDCA-23-aldehyde was obtained by column chromatography. The yield was 78%, and the purity was 95.5%.
[0108] Example 13 Preparation of Nor-CDCA-23-aldehyde
[0109] PhCA (1 g, 2.45 mmol) and 20 mL of a mixed solvent of methanol and water (CH3OH:H2O=3:1 (volume ratio)) were added to a 100 mL three-necked flask in sequence, stirred to dissolve, and then CO2 gas was introduced into the reaction solution (flow rate 6 mL / min). After continuously introducing CO2 gas for 30 minutes, 10 mL of sodium hypochlorite aqueous solution (mass concentration of NaClO is 5%, and it takes about 20 minutes to add) was slowly added to the reaction solution at 60°C and maintaining the CO2 gas flow rate (6 mL / min), and then the reaction was continued to stir at 25°C and maintaining the CO2 gas flow rate (6 mL / min) for 2 hours. TLC detected that the raw material reaction was complete. 5 mL of saturated sodium thiosulfate solution was added to the reaction mixture, and the mixture was stirred for 15 minutes to remove excess sodium hypochlorite. Methanol was evaporated under reduced pressure, and then extracted with ethyl acetate. The organic phases were combined, dried over anhydrous sodium sulfate, and filtered. The filtrate was concentrated under reduced pressure to remove the solvent, and 0.2 g of white solid Nor-CDCA-23-aldehyde was obtained by column chromatography. The yield was 22%, and the purity was 95.1%.
[0110] Example 14 Preparation of Nor-CDCA
[0111]
[0112] (1) PhCA (1 g, 2.45 mmol) and 20 mL of a mixed solvent of methanol and water (CH3OH:H2O=3:1 (volume ratio)) were added to a 100 mL three-necked flask in sequence, and the mixture was stirred to dissolve. Then, CO2 gas (flow rate 6 mL / min) was introduced into the reaction solution. After the CO2 gas was introduced continuously for 30 minutes, 10 mL of sodium hypochlorite aqueous solution (the mass concentration of NaClO was 5%, and the addition took about 20 minutes) was slowly added to the reaction solution at 25°C and a CO2 gas flow rate (6 mL / min). Then, the reaction was continued to stir at 25°C and a CO2 gas flow rate (6 mL / min) for 2 h. TLC detected that the reaction of the raw material was complete. 5 mL of saturated sodium thiosulfate solution was added to the reaction mixture, and the mixture was stirred for 15 minutes to remove excess sodium hypochlorite. The methanol was evaporated under reduced pressure from the reaction mixture, and then extracted with ethyl acetate. The organic phases were combined, dried over anhydrous sodium sulfate, filtered, and the filtrate was concentrated under reduced pressure to remove the solvent to obtain Nor-CDCA-23-aldehyde as a waxy crude product (0.95 g), which was directly used in the next step without further purification.
[0113] (2) Add the Nor-CDCA-23-aldehyde obtained in step (1) into a 100 mL three-necked flask, dissolve it with 20 mL of methanol, then introduce CO2 gas (flow rate 6 mL / min) into the reaction solution, continue to introduce CO2 gas for 30 minutes, slowly drop 10 mL of sodium hypochlorite aqueous solution (the mass concentration of NaClO is 10%, and the addition is completed in about 20 min) into the reaction solution at 60° C. and maintaining the CO2 gas flow rate (6 mL / min), continue stirring and reacting for 3 hours at 60° C. and maintaining the CO2 gas flow rate (6 mL / min), and TLC detection shows that the reaction is complete. Add 10 mL of saturated sodium thiosulfate solution into the reaction mixture, stir for 15 minutes to remove excess sodium hypochlorite, evaporate methanol under reduced pressure, dissolve it in water, then extract it with ethyl acetate, combine the organic phases, dry it with anhydrous sodium sulfate, filter, concentrate the filtrate under reduced pressure to remove the solvent, and separate it by column chromatography to obtain 0.79 g of white solid Nor-CDCA, with a yield of 85% and a purity of 96.7%.
[0114] 1 H NMR (300MHz, MeOD): δ (ppm) 0.73 (s, 3H), 0.93 (s, 3H), 1.00-1.03 (m, 3H), 1.19-1.35 (m, 7H), 1.50-1. 54(m, 6H), 1.61-1.64(m, 3H), 1.87-1.91(m, 6H), 2.23-2.25(m, 2H), 3.32-3.37(m, 1H), 3.80(m, 1H).
[0115] Example 15 Preparation of Nor-UDCA
[0116] Step 1:
[0117]
[0118] Add Nor-CDCA (20 g, 52.8 mmol), CH3OH (100 mL) and hydrochloric acid (158.4 mmol) in a 500 mL single-mouth bottle, stir to dissolve, the reaction solution is clear, slowly add 200 mL of sodium hypochlorite aqueous solution (the mass concentration of NaClO is 5%, about 20 min to add), the solution becomes turbid, continue stirring and reacting at 18 ° C for 2 hours, take a sample TLC (PE: EA = 1: 1) for detection, the raw material disappears. Add water to the reaction mixture, stir, filter, and dry to obtain 18 g of white solid Nor-CDCA7k, 90.6%.
[0119] 1 H NMR (300MHz, CDCl3) δ: 4.65 (m, 1H), 2.88 (m, 1H), 1.30 (s, 3H), 0.98 (m, 3H), 0.68-1.68 (m, 23H) 0.69 (s, 3H).
[0120] Step 2:
[0121]
[0122] In an autoclave, 10 g of Nor-CDCA 7k was dissolved in 70 mL of methanol, and 0.01 mL of pyridine and 0.5 g of 10% palladium carbon were added. Under stirring, the mixture was ventilated with argon three times, and then ventilated with hydrogen three times. Finally, hydrogen was added to a pressure of 5 MPa, and the temperature was raised to 50°C. The reaction was carried out for 10 hours. After the reaction was completed, the mixture was filtered with diatomaceous earth, and methanol was evaporated under reduced pressure to obtain a crude Nor-UDCA product, which was then recrystallized with tert-butyl acetate to obtain 8.43 g of white solid Nor-UDCA, with a yield of 84% and a purity of 97.2%.
[0123] 1 H NMR (300MHz, MeOD): δ (ppm) 0.75 (s, 3H), 0.97 (s, 3H), 1.00-1.03 (m, 3H), 1.24-1.31 (m, 7H), 1.44-1.50 (m, 6H), 1.61-1.64 (m, 3H), 1.83-1.88 (m, 6H), 1.95-2.03 (m, 1H), 2.41-2.45 (m, 1H), 3.48-3.51 (m, 2H).
[0124] Comparative Example 1 Preparation of Nor-CDCA-23-aldehyde
[0125] PhCA (1 g, 2.45 mmol), 20 mL of a mixed solvent of methanol and water (CH3OH:H2O=3:1 (volume ratio)) were added to a 100 mL three-necked flask in sequence, stirred to dissolve, and then 5 mL of a 1 M buffer solution (pH=5.7) (KH2PO4 / K2HPO4) was added. Then, 10 mL of an aqueous sodium hypochlorite solution (the mass concentration of NaClO was 5%, and the addition took about 20 min) was slowly added dropwise to the reaction solution at 25°C, and the reaction pH was maintained at 4-7. After stirring for 30 min, TLC detected that the raw material reaction was complete. 5 mL of a saturated sodium thiosulfate solution was added to the reaction mixture, stirred for 15 minutes to remove excess sodium hypochlorite, concentrated under reduced pressure to remove methanol, and then extracted with ethyl acetate. The organic phases were combined, dried over anhydrous sodium sulfate, filtered, and the filtrate was concentrated under reduced pressure to remove the solvent. 266 mg of white solid Nor-CDCA-23-aldehyde was separated by column chromatography with a yield of 30% and a purity of 95.0%.
[0126] Comparative Example 2 Preparation of Nor-CDCA-23-aldehyde
[0127] PhCA (1 g, 2.45 mmol) and 20 mL of water were added to a 100 mL three-necked flask in sequence, stirred and dissolved, and then CO2 gas (flow rate 6 mL / min) was introduced into the reaction solution. After continuous introduction of CO2 gas for 30 minutes, 10 mL of sodium hypochlorite aqueous solution (the mass concentration of NaClO was 5%, and it was added in about 20 min) was slowly added to the reaction solution at 25°C and the CO2 gas flow rate (6 mL / min), and then the reaction was continued to be stirred for 2 hours at 25°C and the CO2 gas flow rate (6 mL / min). TLC detected that the raw material reaction was complete, 5 mL of saturated sodium thiosulfate solution was added to the reaction mixture, stirred for 15 minutes to remove excess sodium hypochlorite, methanol was evaporated under reduced pressure, and then extracted with ethyl acetate, the organic phases were combined, dried over anhydrous sodium sulfate, filtered, and the filtrate was concentrated under reduced pressure to remove the solvent, and column chromatography was used to separate 0.2 g of white solid Nor-CDCA-23-aldehyde, with a yield of 22% and a purity of 96.1%.
[0128] The technical features of the above-described embodiments may be arbitrarily combined. To make the description concise, not all possible combinations of the technical features in the above-described embodiments are described. However, as long as there is no contradiction in the combination of these technical features, they should be considered to be within the scope of this specification.
[0129] The above-mentioned embodiments only express several implementation methods of the present invention, and the descriptions thereof are relatively specific and detailed, but they cannot be understood as limiting the scope of the invention patent. It should be pointed out that, for ordinary technicians in this field, several variations and improvements can be made without departing from the concept of the present invention, and these all belong to the protection scope of the present invention. Therefore, the protection scope of the patent of the present invention shall be subject to the attached claims.
Claims
1. A method for preparing compound (I), characterized in that: The steps include: Dissolve seal bile acid in a solvent, introduce CO2 gas into the resulting reaction solution, continue to introduce CO2 gas for 10 minutes to 60 minutes, dropwise add sodium hypochlorite aqueous solution into the reaction solution while continuing to introduce CO2 gas, and stir the reaction while continuing to introduce CO2 gas to obtain the product; the reaction formula is as follows: The solvent is methanol, or a mixed solvent of methanol and water; The mass concentration of sodium hypochlorite in the sodium hypochlorite aqueous solution is 2-10%; The flow rate of CO2 gas introduced into every 20mL of reaction solution is 2mL / min-10mL / min.
2. The method for preparing compound (I) according to claim 1, characterized in that: The flow rate of CO2 gas introduced into every 20 mL of reaction solution is 5 mL / min-8 mL / min.
3. The method for preparing compound (I) according to claim 1, characterized in that: The solvent is a mixed solvent of methanol and water in a volume ratio of 1-5:1; and / or, The mass concentration of sodium hypochlorite in the sodium hypochlorite aqueous solution is 4-6%; and / or, The ratio of the seal bile acid to the sodium hypochlorite aqueous solution is 1g: 5mL-20mL; and / or, The ratio of seal bile acid to solvent is 1g:15mL-25mL; and / or, The stirring reaction temperature is 0°C-40°C; and / or, The stirring reaction time is 1h-6h.
4. The method for preparing compound (I) according to claim 3, characterized in that: The solvent is a mixed solvent of methanol and water in a volume ratio of 2-4:1; and / or, The mass concentration of sodium hypochlorite in the sodium hypochlorite aqueous solution is 4.5-5.5%; and / or, The ratio of the seal bile acid to the sodium hypochlorite aqueous solution is 1g:8mL-12mL; and / or, The ratio of the seal bile acid to the solvent is 1g: 18mL-22mL; and / or, The stirring reaction temperature is 5°C-30°C; and / or, The stirring reaction time is 1h-3h.
5. A method for preparing compound (II), characterized in that: The steps include: Compound (I) is dissolved in a solvent, and CO2 gas is introduced into the obtained reaction solution. After the CO2 gas is introduced continuously for 10 to 60 minutes, an aqueous sodium hypochlorite solution is added dropwise to the reaction solution while the CO2 gas is introduced continuously. The reaction is stirred while the CO2 gas is introduced continuously to obtain the product. The reaction formula is as follows: The mass concentration of sodium hypochlorite in the sodium hypochlorite aqueous solution is 7-15%; The method for preparing the compound (I) is as described in any one of claims 1 to 4.
6. The method for preparing compound (II) according to claim 5, characterized in that: The flow rate of CO2 gas introduced into every 20 mL of reaction solution is 2 mL / min-10 mL / min; and / or, The mass concentration of sodium hypochlorite in the sodium hypochlorite aqueous solution is 9-11%; and / or, The solvent is methanol; and / or, The ratio of the compound (I) to the sodium hypochlorite aqueous solution is 1 g: 5 mL-20 mL; and / or, The ratio of the compound (I) to the solvent is 1 g: 15 mL-35 mL; and / or, The stirring reaction is carried out at a temperature of 50° C. to 70° C. and for a time of 2 hours to 5 hours.
7. A method for preparing Nor-UDCA, characterized in that: The steps include: (1) preparing the compound (II) by the method for preparing the compound (II) according to any one of claims 5 to 6; (2) Compound (II) is subjected to oxidation reaction to obtain compound (III); (3) The compound (III) is subjected to a reduction reaction to obtain the Nor-UDCA; the reaction formula is as follows: 。 8. The method for preparing Nor-UDCA according to claim 7, characterized in that: Step (2) comprises: under the action of an acid, the compound (II) undergoes an oxidation reaction with an oxidant to obtain the compound (III); the acid is hydrochloric acid, HOAc or H3PO4; the oxidant is an aqueous solution of sodium hypochlorite; Step (3) comprises: under the catalytic action of pyridine and palladium on carbon, the compound (III) undergoes a reduction reaction with hydrogen to obtain the Nor-UDCA.
9. The method for preparing Nor-UDCA according to claim 8, characterized in that: The solvent for the oxidation reaction in step (2) is methanol; and / or, The mass concentration of sodium hypochlorite in the sodium hypochlorite aqueous solution in step (2) is 2-10%; and / or, The molar ratio of compound (II) to acid in step (2) is 1:2.5-3.5; and / or, The ratio of the compound (II) to the aqueous sodium hypochlorite solution in step (2) is 1 g: 5 mL-15 mL; and / or, The oxidation reaction in step (2) is carried out at a temperature of 10°C to 30°C and for a time of 1 hour to 4 hours; and / or, The solvent for the reduction reaction in step (3) is methanol; and / or, The palladium carbon in step (3) is 10% palladium carbon, and the ratio of compound (III), pyridine and palladium carbon is 1g:0.0005mL-0.0015mL:0.04g-0.06g; and / or, The pressure of the hydrogen in step (3) is 4 MPa-6 MPa; and / or, The temperature of the reduction reaction in step (3) is 40°C-60°C, and the time is 8 hours-12 hours.
Citation Information
Patent Citations
Stabilized acrylonitrile / styrene / acrylic ester molding compositions
WO2012007268A1
Chenodeoxycholic acid compound and preparation method and application thereof
CN105348354A
New method for producing ursodesoxycholic acid from duck bile powder
CN105936641A
Methods for preparation of bile acids and derivatives thereof
CN108137643A
Preparation method of high-purity 3 alpha-hydroxy-7-oxo-5 beta-cholanic acid
CN108218942A
